By: Parker H.B. No. 3707
A BILL TO BE ENTITLED
AN ACT
relating to value-based arrangements for prescription drugs in
Medicaid.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
SECTION 1. Section 531, Government Code, is amended by
adding Section 531.0701 to read as follows:
Sec. 531.0701. VALUE-BASED ARRANGEMENTS. Subject to
531.071, the commission may enter into a written agreement with a
manufacturer of prescription drugs as defined by 42 U.S.C. Section
1396r-8(k)(5) and its subsequent amendments, including a
subsidiary or affiliate of a manufacturer, based on outcomes data,
or other metrics agreed to in writing by the state and a
pharmaceutical manufacturer. Such agreements may include but not
be limited to rebates, discounts, price reductions, contributions,
risk sharing, reimbursements, deferral of payments (e.g.
installment payments), guarantees, patient care, shared savings
payments, withholds, or bonuses or anything of value.
SECTION 2. The Health and Human Services Commission shall
amend contracts with managed care plans to ensure those contracts
comply with Section 531.0701, Government Code, as added by this
Act.
SECTION 3. This Act takes effect September 1, 2019.